|
Market Closed -
Other stock markets
|
Pre-market 12:41:28 | |||
| 26.04 USD | +1.36% |
|
25.98 | -0.25% |
| 12:18pm | Pfizer Says US FDA Expands Hemophilia Drug Approval to Younger Patients | MT |
| 11:54am | US FDA approves Pfizer's bleeding disorder drug for children | RE |
Chart calendar Pfizer Inc.
Upcoming events on Pfizer Inc.
No events available
Past events on Pfizer Inc.
| 06/06/2026 | Information meeting | 16:00 |
| 05/05/2026 | Earnings release - Q1 2026 | |
| 05/05/2026 | Earnings presentation | 15:00 |
| 23/04/2026 | Présentation aux Actionnaires / Analystes | 14:00 |
| 23/04/2026 | Annual General Meeting | 14:00 |
| 03/02/2026 | Earnings release - Q4 2025 | 15:00 |
| 03/02/2026 | Earnings presentation | 15:00 |
| 10/11/2025 | Information meeting | 13:30 |
| 04/11/2025 | Earnings presentation | 15:00 |
| 04/11/2025 | Earnings release - Q3 2025 | |
| 05/08/2025 | Earnings presentation | 15:00 |
| 12/06/2025 | Information meeting | 15:00 |
Past dividends on Pfizer Inc.
| 08/05/2026 | Ex-dividend date - 0.43 USD | 05:00 |
| 23/01/2026 | Ex-dividend date - 0.43 USD | 05:00 |
| 07/11/2025 | Ex-dividend date - 0.43 USD | 05:00 |
| 25/07/2025 | Ex-dividend date - 0.43 USD | 05:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 58 496 59 105 -1.03% | 63 627 63 071 0.88% | 62 579 61 941 1.03% | 61 690 | 59 320 | 55 358 |
|
EBITDA Million USD | Released Forecast Spread | 15 590 11 249 38.59% | 28 801 25 482 13.03% | 28 563 25 004 14.23% | 25 344 | 24 194 | 21 226 |
|
EBIT Million USD | Released Forecast Spread | 9 300 8 509 9.3% | 21 788 20 589 5.82% | 21 971 21 223 3.53% | 21 051 | 19 765 | 17 667 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 058 2 301 -54.02% | 8 023 11 544 -30.5% | 7 520 12 438 -39.54% | 11 253 | 13 245 | 11 666 |
|
Net income Million USD | Released Forecast Spread | 2 119 3 040 -30.29% | 8 031 9 732 -17.47% | 7 771 12 287 -36.75% | 11 070 | 10 717 | 9 432 |
|
EPS USD | Released Forecast Spread | 0,37 0,72 -48.44% | 1,41 1,70 -17.17% | 1,36 2,14 -36.34% | 2,14 | 1,98 | 1,62 |
| Announcement Date | 30/01/24 | 04/02/25 | 03/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17 702 14 865 19.08% | 17 763 17 264 2.89% | 13 715 14 051 -2.39% | 14 653 13 531 8.29% | 16 654 16 502 0.92% | 17 557 16 828 4.33% | 14 451 13 802 4.7% | 14 412 | 16 149 | 16 790 | 13 298 | 14 155 | 16 016 | 16 488 |
|
EBITDA Million USD | Released Forecast Spread | 7 478 4 647 60.92% | 6 391 4 136 54.54% | 7 548 6 180 22.14% | 6 940 5 487 26.49% | 7 303 6 229 17.23% | 6 770 6 073 11.47% | 7 172 6 329 13.32% | 5 964 | 7 195 | 5 943 | 5 334 | |||
|
EBIT Million USD | Released Forecast Spread | 7 035 3 978 76.86% | 4 672 3 357 39.18% | 5 930 4 982 19.02% | 5 315 4 410 20.51% | 5 641 4 704 19.93% | 5 083 4 275 18.89% | 5 559 5 329 4.31% | 5 009 | 6 206 | 4 961 | 4 809 | 5 060 | 6 154 | 4 685 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4 715 2 616 80.24% | -10,0 2 104 -100.48% | 2 785 3 880 -28.22% | 3 044 2 468 23.34% | 3 334 3 240 2.9% | -1 642 3 002 -154.71% | 3 170 3 966 -20.07% | 3 092 | 4 645 | 2 544 | ||||
|
Net income Million USD | Released Forecast Spread | 4 465 1 725 158.79% | 410 1 002 -59.1% | 2 967 2 913 1.86% | 2 910 2 063 41.07% | 3 541 2 334 51.72% | -1 648 2 208 -174.64% | 2 687 2 981 -9.86% | 2 518 | 3 556 | 2 159 | 2 777 | 3 168 | 4 110 | 2 878 |
|
EPS USD | Released Forecast Spread | 0,78 0,30 160.81% | 0,07 0,20 -65.43% | 0,52 0,51 2.91% | 0,51 0,36 41.65% | 0,62 0,44 42.49% | -0,29 0,39 -173.87% | 0,47 0,52 -9.48% | 0,44 | 0,62 | 0,38 | 0,49 | 0,56 | 0,72 | 0,50 |
| Announcement Date | 29/10/24 | 04/02/25 | 29/04/25 | 05/08/25 | 04/11/25 | 03/02/26 | 05/05/26 | - | - | - | - | - | - | - |
| Today | Présentation aux Actionnaires / Analystes | 16:00 | |
| 09/06/2026 | Présentation aux Actionnaires / Analystes | 05:30 | |
| 09/06/2026 | Annual General Meeting | ||
| 09/06/2026 | Présentation aux Actionnaires / Analystes | 14:00 | |
| 09/06/2026 | Ex-dividend date - 0.016 CNY | 05:00 | |
| 09/06/2026 | Ex-dividend date - 0.7 CNY | 05:00 | |
| 09/06/2026 | Ex-dividend date - 0.1 CNY | 05:00 | |
| 09/06/2026 | Annual General Meeting | 02:00 | |
| 09/06/2026 | Earnings presentation | 06:00 | |
| 09/06/2026 | Présentation aux Actionnaires / Analystes |
Past sector events for Pfizer Inc.
| Today | Information meeting | 00:30 | |
| Today | Annual General Meeting | 02:00 | |
| Today | Extraordinary General Meeting | 07:30 | |
| 05/06/2026 | Présentation aux Actionnaires / Analystes | 03:30 | |
| 05/06/2026 | Annual General Meeting | 16:30 | |
| 05/06/2026 | Annual General Meeting | 02:30 | |
| 05/06/2026 | Annual General Meeting | 07:00 | |
| 05/06/2026 | Annual General Meeting | 04:00 | |
| 05/06/2026 | Extraordinary General Meeting | 03:00 | |
| 05/06/2026 | Earnings presentation | 08:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PFE Stock
- Calendar Pfizer Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















